City Clinical Hospital No. 2

Kharkiv, Kharkiv Oblast 61037

0 studies enrolling now · 4 studies all time

What they study most

Crohn's Disease, Type 2 Diabetes Mellitus, Ulcerative Colitis

Studies at this site

• A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes — Completed
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed